शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ANUHPHRNSEAnuh Pharma Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 23 May, 2025 · 21:22 IST

Anuh Pharma Limited has informed the Exchange regarding the Audited Financial Results for the Board meeting held on May 23, 2025.

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.6%Reaction day
₹100.50
prior close
₹102.50
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.6%+2.0% vs market
Pharmaceuticals peers, median of 148sector+0.4%+2.2% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 2.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.5
10m
+1.5
15m
+1.4
30m
+0.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.6+0.6+2.0+0.4+2.2
Next day
+5.0+0.5+4.5+0.3+4.6
2d
+6.0+0.8+5.2+0.5+5.5
3d
+6.0+1.2+4.8+1.0+5.0
4d
+4.8+1.5+3.3+0.6+4.2
5d
+8.6+1.6+7.0-0.1+8.7
1w
+7.5+1.8+5.7+0.1+7.4
15d
+5.8+3.3+2.5+1.5+4.3
1m
+3.3+3.1+0.2-1.2+4.5
2m
-3.5+2.3-5.8+0.9-4.4
3m
-12.9+0.2-13.1-1.6-11.2
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma Limited has submitted its audited financial results to the NSE following a board meeting held on May 23, 2025. The filing is a standard compliance disclosure informing the exchange that the board has approved and released the company's audited financial performance. Detailed figures such as revenue, profit after tax, margins, and auditor observations are not included in the headline and would need to be reviewed in the full results document. This is a routine regulatory filing tied to the company's annual results announcement.

Likely market impact

No immediate stock price impact is expected from the filing itself, as it is a procedural disclosure confirming submission of results. Investors should review the detailed audited numbers separately to assess the company's actual financial performance and any year-on-year trends.